Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SANOFI-AVENTIS U.S. LLC v. MYLAN INC. et al
Case Number:
3:17-cv-02763
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 13, 2017
Mylan Can't Move Sanofi's EpiPen Antitrust Suit
A New Jersey federal judge on Wednesday denied EpiPen maker Mylan's motion to move to Kansas a lawsuit alleging that it offered rebates to insurers that refused to cover a competing Sanofi-Aventis epinephrine auto-injector.
-
April 24, 2017
Mylan Rebates Doomed EpiPen Rival, Sanofi Says
EpiPen maker Mylan improperly preserved its monopoly on epinephrine auto-injectors by offering big rebates to insurers that refused to cover a competing product, Sanofi-Aventis charged in a complaint filed Monday in New Jersey federal court.